These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21678399)

  • 1. Hair dye use and risk of bladder cancer in the New England bladder cancer study.
    Koutros S; Silverman DT; Baris D; Zahm SH; Morton LM; Colt JS; Hein DW; Moore LE; Johnson A; Schwenn M; Cherala S; Schned A; Doll MA; Rothman N; Karagas MR
    Int J Cancer; 2011 Dec; 129(12):2894-904. PubMed ID: 21678399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.
    Gago-Dominguez M; Bell DA; Watson MA; Yuan JM; Castelao JE; Hein DW; Chan KK; Coetzee GA; Ross RK; Yu MC
    Carcinogenesis; 2003 Mar; 24(3):483-9. PubMed ID: 12663508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms.
    Espinoza F; Silverman D; Kogevinas M; Creus A; Fernández F; García-Closas M; Tardon A; García-Closas R; Serra C; Carrato A; Rothman N; Dosemeci M; Malats N; Marcos R
    Cancer Lett; 2008 May; 263(2):259-66. PubMed ID: 18262724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
    Morton LM; Bernstein L; Wang SS; Hein DW; Rothman N; Colt JS; Davis S; Cerhan JR; Severson RK; Welch R; Hartge P; Zahm SH
    Carcinogenesis; 2007 Aug; 28(8):1759-64. PubMed ID: 17522066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
    Moore LE; Baris DR; Figueroa JD; Garcia-Closas M; Karagas MR; Schwenn MR; Johnson AT; Lubin JH; Hein DW; Dagnall CL; Colt JS; Kida M; Jones MA; Schned AR; Cherala SS; Chanock SJ; Cantor KP; Silverman DT; Rothman N
    Carcinogenesis; 2011 Feb; 32(2):182-9. PubMed ID: 21037224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain.
    Kogevinas M; Fernandez F; Garcia-Closas M; Tardon A; Garcia-Closas R; Serra C; Carrato A; Castano-Vinyals G; Yeager M; Chanock SJ; Lloreta J; Rothman N; Real FX; Dosemeci M; Malats N; Silverman D
    Eur J Cancer; 2006 Jul; 42(10):1448-54. PubMed ID: 16740387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in xenobiotic metabolic pathway genes, personal hair dye use, and risk of non-Hodgkin lymphoma.
    Zhang Y; Hughes KJ; Zahm SH; Zhang Y; Holford TR; Dai L; Bai Y; Han X; Qin Q; Lan Q; Rothman N; Zhu Y; Leaderer B; Zheng T
    Am J Epidemiol; 2009 Nov; 170(10):1222-30. PubMed ID: 19822571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer risk and personal hair dye use.
    Andrew AS; Schned AR; Heaney JA; Karagas MR
    Int J Cancer; 2004 Apr; 109(4):581-6. PubMed ID: 14991581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
    Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
    J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye.
    Nohynek GJ; Skare JA; Meuling WJ; Hein DW; De Bie AT; Toutain H
    Food Chem Toxicol; 2004 Nov; 42(11):1885-91. PubMed ID: 15350687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer.
    Yuan JM; Chan KK; Coetzee GA; Castelao JE; Watson MA; Bell DA; Wang R; Yu MC
    Carcinogenesis; 2008 Jul; 29(7):1386-93. PubMed ID: 18544563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J; Liang D; Wang Y; Lu C; Wu X
    Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.